BBI Solutions have launched over twenty new antibodies, extending their portfolio to include new cardiac, cancer, inflammation and fertility markers after reacting to demands in the marketplace (BBI Solutions, 2017). The antibodies come in a range of monoclonal and polyclonal varieties and are available for sampling.

BBI have noticed that interest in fertility markers has grown substantially in emerging markets, especially China, due to the change in the countries’ one child policy.

In the developed world the average age of women when they have their first child has risen over the past four decades. The risk of infertility increases with age, which means an increased need for fertility tests.

Aside from this, both cardiac and cancer conditions have some of the highest morbidity rates worldwide, and the industry is continuously researching in these areas to find ways of improving diagnosis. Therefore, BBI have focused on improving their range of biomarkers in these areas to meet the needs of the market and help to work towards tackling life threatening diseases.

Dr. James Steggles, BBI’s Commercial Manager for Antibodies said “At BBI we continually monitor trends in the market and listen to customer’s needs, so that we can react to market demands and provide products that will help to improve things like disease diagnosis and in this case help people that may have fertility issues. Our overarching vision is to create a world where everyone has the opportunity for a better quality of life, and launching products like this is our way of achieving this goal.”

The new products include CYFRA 21-1 a tumour marker of non-small cell lung cancer, prostate specific antigen, H-FABP used as a biomarker for myocardial ischemia and estradiol, which is important in the regulation of the female reproductive cycles, as well as many more.

BBI’s new antibodies have been stringently tested before being launched. James Steggles said “We are confident that these are high performing products for their complementing applications, meeting high specifications and sensitivity.”

BBI can provide flexible batch sizes and bulk order options. Many of the antibodies also have a recommended matched pair, which will save customers time and money on antibody screening.